risedronate sodium
Sponsors
Alliance for Clinical Trials in Oncology, AstraZeneca, Sanofi, ETOP IBCSG Partners Foundation, NCIC Clinical Trials Group
Conditions
Breast CancerColles' FractureOsteogenesis ImperfectaOsteoporosisOsteoporosis, PostmenopausalProstate Cancer
Phase 2
Phase 3
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
CompletedNCT00043069
Start: 2002-11-30End: 2010-01-31Updated: 2016-12-07
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
CompletedNCT00054418
Start: 2003-03-31End: 2008-05-31Updated: 2016-07-13
Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS
WithdrawnNCT00324714
Start: 2003-02-28Updated: 2012-11-29
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial
CompletedNCT00354302
Start: 2006-04-24End: 2012-01-06Updated: 2020-04-02
Phase 4
Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer
CompletedNCT00082277
Start: 2004-04-30End: 2007-10-31Updated: 2011-01-26
OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women
CompletedNCT00130403
Start: 2004-03-31End: 2007-03-31Updated: 2011-01-11
Risedronate Sodium in Post Menopausal Osteoporosis
CompletedNCT00453492
Start: 2004-01-31Target: 246Updated: 2008-03-11
SOLID-Effect of Risedronate Sodium at Distal Radius in Colle's Fracture.
CompletedNCT00460733
Start: 2007-03-31End: 2011-09-30Updated: 2011-10-04
Satisfaction and Compliance of Risedronate in PMO
CompletedNCT00549965
Start: 2003-10-31Updated: 2007-10-30
A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis
CompletedNCT00632216
Start: 2004-05-31End: 2006-05-31Updated: 2008-03-11